Quarterly report pursuant to Section 13 or 15(d)

Nature of Business (Details)

v3.19.3.a.u2
Nature of Business (Details)
$ / shares in Units, $ in Millions
6 Months Ended
Feb. 23, 2017
USD ($)
$ / shares
shares
Dec. 31, 2019
ft²
segment
item
Jan. 13, 2016
USD ($)
Dec. 31, 2015
Nature of Business [Line Items]        
Number of Operating Segments | segment   1    
Noncontrolling Interest, Amount Represented by Preferred Stock | $ $ 13      
Shares exchanged for ownership interest 29,990,000      
Number Of Lines Of Business | item   3    
Ibio Do Brasil Biofarmatcutica Ltda [Member]        
Nature of Business [Line Items]        
Noncontrolling Interest, Ownership Percentage by Parent   99.00%    
iBio CMO [Member]        
Nature of Business [Line Items]        
Noncontrolling Interest, Ownership Percentage by Parent 99.99%     100.00%
Noncontrolling Interest, Amount Represented by Preferred Stock | $     $ 15  
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners     70.00%  
Second Eastern Affiliate [Member]        
Nature of Business [Line Items]        
Lease Term   34 years    
Preferred Tracking Stock [Member]        
Nature of Business [Line Items]        
Shares exchanged for ownership interest 1      
Preferred Stock, Par or Stated Value Per Share | $ / shares $ 0.001      
iBio CDMO LLC [Member]        
Nature of Business [Line Items]        
Shares exchanged for ownership interest 1      
Second Eastern Affiliate [Member]        
Nature of Business [Line Items]        
Area of Land | ft²   139,000    
Second Eastern Affiliate [Member] | iBio CMO [Member]        
Nature of Business [Line Items]        
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners     30.00%